InspireMD (NSPR) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, with voting available online or in person in Tel Aviv, Israel.

• Shareholders are encouraged to review proxy materials and vote by June 2, 2026.

Voting matters and shareholder proposals

• Election of three Class III directors for three-year terms: Marvin Slosman, Raymond Cohen, and Dan Dearen, all recommended by the board.

• Proposal to amend the Certificate of Incorporation to increase authorized common stock from 150,000,000 to 250,000,000.

• Ratification of Kesselman & Kesselman as independent auditors for the year ending December 31, 2026.

• Approval to adjourn the meeting if necessary to solicit more votes for the main proposals.

Board of directors and corporate governance

• Board recommends all director nominees for election.